Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach

MLA

Joris Vermeesch, et al. “Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-Free Approach.” Molecular Therapy, vol. 20, no. 10, Oct. 2012, pp. 1953–67. EBSCOhost, https://doi.org/10.1038/mt.2012.117.

APA

Joris Vermeesch, Sayandip Mukherjee, Gudrun E. Moore, Anthony Atala, Adrian J. Thrasher, Gemma N. Jones, Jennifer M. Frost, Nicholas M. Fisk, Michael P. Blundell, Pascale V. Guillot, Daniel Nettersheim, T Selvee Ramasamy, Kenneth Lay, Beata Nowakowska, Mara Cananzi, Dafni Moschidou, Paolo De Coppi, Hassan Abdulrazzak, Anju Phoolchund, … Hubert Schorle. (2012). Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach. Molecular Therapy, 20(10), 1953–1967. https://doi.org/10.1038/mt.2012.117

Chicago

Joris Vermeesch, Sayandip Mukherjee, Gudrun E. Moore, Anthony Atala, Adrian J. Thrasher, Gemma N. Jones, Jennifer M. Frost, et al. 2012. “Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-Free Approach.” Molecular Therapy 20 (10): 1953–67. doi:10.1038/mt.2012.117.